Abstract
Fecal occult blood test (FOBT) was traditionally used as a non-invasive screening tool for colorectal cancer (CRC) screening, however it is increasingly used in the inpatient setting despite the controversy for indications other than CRC screening. Moreover, FOBT has a high false positive rate which may lead to an increased in unnecessary investigations and health care cost. In phase I of this 2 phase study, we aim to identify and evaluate practice trends in utilizing FOBT in the inpatient setting and its impact on clinical management and patient outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
